Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

5-HT3 Antagonists (Antiemetics) and Cardiac Safety Using an Active Surveillance Approach

NCT02436798 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT02436798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02436798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
5-HT3 Antagonists (Antiemetics) and Cardiac Safety Using an Active Surveillance Approach
Lead sponsor
University of British Columbia
Phase
Observational
Overall status
Completed
Start date
June 30, 2014
Completion date
August 31, 2020
Enrollment
266 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse reaction to other drugs and medicines